GAO Recommends Wider Look at Opioid Use by Medicare Beneficiaries

Drug Industry Daily
Federal administrators of the Medicare Part D prescription-drug program should expand their oversight of opioid prescriptions and focus their surveillance of potential drug abuse more tightly on opioids, the U.S. Government Accountability Office said in a report.

To View This Article:


Subscribe To Drug Industry Daily